All > Opioid Dependence

OCM-RISE for Opioid Court Model

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Opioid Court Model+2 MoreOCM-RISE - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to study how to best implement a new court model - the opioid court model - across New York State in order to reduce overdose, opioid use disorder, and recidivism.

Eligible Conditions
  • Opioid Court Model
  • Medication-Assisted Treatment (MAT)
  • Opioid Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Cancer Survivorship Leadership Training for Clergy Wives and Widows
1
DOMVANALIMAB
2
CI-581-a

Study Objectives

4 Primary · 6 Secondary · Reporting Duration: Through study completion, an average of 30 months

At study completion
Acceptability of the opioid court
Month 30
Adoption of OCM RISE
Defendant Characteristics
Inter-agency Organizational Features
Knowledge, Attitudes towards MOUD
Leadership innovation
Number of court participants who are provided medication for Opioid Use Disorder (MOUD) Initiation
Number of court participants who are referred for opioid treatment
Number of defendants who are screened for opioid use after arrest
Number of participants who are abstinent from opioid use
Number of participants who are retained in treatment for at least 60 days
Number of participants who graduate from court
Number of participants who recidivate within 12 months following court completion
Organizational climate, support, and functioning
Perceived Importance of Cascade Behaviors
Perceived Potential Sustainability of OCM
Practice change
Self-Efficacy to address Opioid Use Disorder
Structural Organizational Characteristics
Sustainability of OCM RISE

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Cancer Survivorship Leadership Training for Clergy Wives and Widows
1
DOMVANALIMAB
3
CI-581-a

Trial Design

1 Treatment Group

OCM-RISE
1 of 1

Experimental Treatment

3440 Total Participants · 1 Treatment Group

Primary Treatment: OCM-RISE · No Placebo Group · N/A

OCM-RISE
Behavioral
Experimental Group · 1 Intervention: OCM-RISE · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 30 months

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
457 Previous Clinical Trials
145,150 Total Patients Enrolled
Center for Court InnovationOTHER
2 Previous Clinical Trials
613 Total Patients Enrolled
New York State Unified Court SystemUNKNOWN
Center on AddictionUNKNOWN
Columbia UniversityOTHER
1,297 Previous Clinical Trials
1,609,797 Total Patients Enrolled
Weill Medical College of Cornell UniversityOTHER
989 Previous Clinical Trials
1,335,490 Total Patients Enrolled
Edward Nunes, MDPrincipal InvestigatorColumbia University/NYSPI
1 Previous Clinical Trials
125 Total Patients Enrolled
Katherine S Elkington, PhDPrincipal InvestigatorColumbia University/NYSPI
1 Previous Clinical Trials
22 Total Patients Enrolled
Milton L Wainberg, MDPrincipal InvestigatorColumbia University/NYSPI
4 Previous Clinical Trials
1,832 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are employed by the Unified Court System/County Court in participating county.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top